Family Planning Clinics: Strain of Norplant's High Up-Front Costs Has Subsided
HEHS-95-7
Published: Oct 07, 1994. Publicly Released: Nov 08, 1994.
Skip to Highlights
Highlights
GAO reviewed pricing issues concerning the Norplant contraceptive, focusing on determining how: (1) Norplant's U.S. price compares with its price in Canada and other countries; (2) the price of Norplant affects the budgets of family planning clinics; and (3) the U.S. price affects the demand for and acceptability of Norplant.
Full Report
Office of Public Affairs
Topics
Reproductive health careComparative analysisContraceptionDeveloping countriesHealth care cost controlHealth care facilitiesHealth care planningHealth care servicesHealth services administrationFamily planning clinics